LIAISON XL MUREX HCV Ab - Hepatitis C virus total antibody IVD, kit, chemiluminescent assay

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

DiaSorin Australia Pty Ltd

Class:

Class 4

Manufactured by:

DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy

Therapeutic area:

48366 - Hepatitis C virus total antibody IVD, kit, chemiluminescent assay

Therapeutic indications:

The LIAISON? XL MUREX HCV Ab assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific antibodies to hepatitis C virus (anti-HCV) in human serum or plasma samples. The test has to be performed on the LIAISON? XL analyzers only. For the qualitative determination of specific antibodies to hepatitis C virus (anti-HCV) in human serum or plasma samples. Post mortem samples collected up to 24 hours after death have been tested and may be also used in the assay.

Authorization status:

A

Authorization date:

2013-07-20